These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8327030)

  • 21. Serial estimation of serum interleukin 6 during treatment with recombinant human erythropoietin in patients with the anemia of rheumatoid arthritis.
    Jongen-Lavrencic M; Swaak AJ; Vreugdenhil G
    J Rheumatol; 1993 Jul; 20(7):1253-5. PubMed ID: 8371234
    [No Abstract]   [Full Text] [Related]  

  • 22. The biology and clinical applications of erythropoietin and the colony-stimulating factors.
    Petersdorf SH; Dale DC
    Adv Intern Med; 1995; 40():395-428. PubMed ID: 7747654
    [No Abstract]   [Full Text] [Related]  

  • 23. [Erythropoietin in the prevention and treatment of anemias (a review of the literature)].
    Shevchenko IuL; Danil'chenko VV; Zhiburt EB; Serebrianaia NB; Khubulava GG; Belevitin AB
    Voen Med Zh; 1996 Nov; 317(11):45-8. PubMed ID: 9036631
    [No Abstract]   [Full Text] [Related]  

  • 24. Erythropoietin treatment of erythropoietin-deficient anemia without renal disease during pregnancy.
    Harris SA; Payne G; Putman JM
    Obstet Gynecol; 1996 May; 87(5 Pt 2):812-4. PubMed ID: 8677097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant human erythropoietin for long-term treatment of anemia in paroxysmal nocturnal hemoglobinuria.
    Balleari E; Gatti AM; Mareni C; Massa G; Marmont AM; Ghio R
    Haematologica; 1996; 81(2):143-7. PubMed ID: 8641643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful treatment of pure red cell aplasia in systemic lupus erythematosus with erythropoietin.
    Orbach H; Ben-Yehuda A; Ben-Yehuda D; Manor D; Rubinow A; Naparstek Y
    J Rheumatol; 1995 Nov; 22(11):2166-9. PubMed ID: 8596164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined use of erythropoietin and G-CSF in the treatment of myelodysplastic syndromes.
    Haematologica; 1999 Dec; 84(12):1057. PubMed ID: 10586204
    [No Abstract]   [Full Text] [Related]  

  • 28. Correction of anaemia in haemodialysis patients with recombinant human erythropoietin.
    Boran M; Dalva I; Yazicioğlu A; Akbay E; Cetin S
    Int Urol Nephrol; 1993; 25(2):197-203. PubMed ID: 8365853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutic use of hematopoietic growth factors. I. Erythropoietin and thrombopoietin].
    Royer B; Arock M
    Ann Biol Clin (Paris); 1998; 56(2):143-52. PubMed ID: 9754239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Erythropoietin in the treatment of anemias].
    Spicka I; Klener P; Lachmanová J; Háber J
    Vnitr Lek; 1996 Mar; 42(3):197-9. PubMed ID: 8686210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of recombinant human erythropoietin on soluble interleukin 2 receptor (SIL-2R) levels in haemodialysis patients.
    Altun B; Erdem Y; Haznedaroğlu I; Gürsoy M; Yasavul U; Turgan C; Cağlar S; Kirazli S
    Nephrol Dial Transplant; 1995 Nov; 10(11):2164. PubMed ID: 8643199
    [No Abstract]   [Full Text] [Related]  

  • 32. [Erythropoietin in hematology and oncology. I. Chronic anemia in malignant disease and the pharmacology of erythropoietin].
    Adam Z; Krejcí M; Vorlícek J
    Vnitr Lek; 1996 Apr; 42(4):285-9. PubMed ID: 8693717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythropoietin in stem cell transplantation.
    Miller CB; Lazarus HM
    Bone Marrow Transplant; 2001 May; 27(10):1011-6. PubMed ID: 11438814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of angiotensin II receptor antagonist on the exogenous erythropoietin requirement of haemodialysis patients.
    Chew CG; Weise MD; Disney AP
    Nephrol Dial Transplant; 1999 Aug; 14(8):2047-9. PubMed ID: 10462304
    [No Abstract]   [Full Text] [Related]  

  • 35. Erythropoietin enhances immune responses in mice.
    Katz O; Gil L; Lifshitz L; Prutchi-Sagiv S; Gassmann M; Mittelman M; Neumann D
    Eur J Immunol; 2007 Jun; 37(6):1584-93. PubMed ID: 17458859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythropoietin therapy in renal failure.
    Paganini EP; Miller T
    Adv Intern Med; 1993; 38():223-43. PubMed ID: 8438638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythropoietin: mechanisms of action and indications for treatment.
    Vreugdenhil G; Frenken LA; Koene RA
    Neth J Med; 1993 Jun; 42(5-6):187-202. PubMed ID: 8377877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recombinant human erythropoietin].
    Stabile C
    Rev Assoc Med Bras (1992); 1992; 38(2):55-6. PubMed ID: 1307066
    [No Abstract]   [Full Text] [Related]  

  • 39. Recombinant human erythropoietin plays a pivotal role as a topical stem cell activator to reverse effects of damage to the skin in aging and trauma.
    Bader A; Machens HG
    Rejuvenation Res; 2010 Aug; 13(4):499-500. PubMed ID: 20695821
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of recombinant erythropoietin on peripheral T lymphocytes.
    Hisatomi K; Nakao M; Isomura T; Kosuga K; Itoh K
    J Thorac Cardiovasc Surg; 1995 Apr; 109(4):809. PubMed ID: 7715233
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.